The Technical Analyst
Select Language :
Aclaris Therapeutics Inc [ACRS]

Exchange: NASDAQ Sector: Healthcare Industry: Diagnostics & Research

Aclaris Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Aclaris Therapeutics Inc is listed at the  Exchange

6.78% $1.260

America/New_York / 27 mar 2024 @ 16:00


Aclaris Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 89.37 mill
EPS: -1.270
P/E: -0.990
Earnings Date: May 05, 2024
SharesOutstanding: 70.93 mill
Avg Daily Volume: 1.778 mill
RATING 2024-03-27
B
Neutral
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Neutral
Return On Asset: Buy
DE: Sell
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.990 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.05x
Company: PE -0.990 | industry: PE 18.71
DISCOUNTED CASH FLOW VALUE
$-0.0727
(-105.77%) $-1.333
Date: 2024-03-28
Expected Trading Range (DAY)

$ 1.158 - 1.362

( +/- 8.10%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-01 Walker Neal Buy 9 466 Common Stock
2024-03-01 Walker Neal Sell 3 223 Common Stock
2024-03-01 Walker Neal Sell 9 466 Restricted Stock Units
2024-03-02 Monahan Joseph Buy 12 500 Common Stock
2024-03-02 Monahan Joseph Sell 3 531 Common Stock
INSIDER POWER
78.11
Last 99 transactions
Buy: 2 308 311 | Sell: 303 206

Forecast: 16:00 - $1.260

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $1.260
Forecast 2: 16:00 - $1.260
Forecast 3: 16:00 - $1.260
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $1.260 (6.78% )
Volume 1.273 mill
Avg. Vol. 1.778 mill
% of Avg. Vol 71.62 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Aclaris Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Aclaris Therapeutics Inc

RSI

Intraday RSI14 chart for Aclaris Therapeutics Inc

Last 10 Buy & Sell Signals For ACRS

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$1.175N/AActive
Profile picture for
            Aclaris Therapeutics Inc

ACRS

Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of laboratory services. The company also develops Zunsemetinib, an MK2 inhibitor for the treatment of moderate to severe rheumatoid and Psoriatic arthritis, and Hidradenitis suppurativa; and ATI-1777, a soft JAK 1/3 inhibitor for the treatment of moderate to severe atopic dermatitis. In addition, it develops ATI-2138, an ITK/TXK/JAK3 inhibitor as a potential treatment for T cell-mediated autoimmune diseases; Gut-Biased Program for inflammatory bowel disease; and ATI-2231, an MK2 inhibitor treatment for pancreatic and metastatic breast cancer. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

Last 10 Buy Signals

Date Signal @
^TA125.TAMar 28 - 07:33PTS2 035.70
MGCUSDMar 28 - 07:392 228.90
EGXUSDMar 28 - 07:46199.84
SBDUSDMar 28 - 07:45$4.72
OETHUSDMar 28 - 07:453 570.56
NANOUSDMar 28 - 07:46$1.655
LDOUSDMar 28 - 07:452.94
^STOXXMar 28 - 07:31512.48
SCNSOLUSDMar 28 - 07:44219.77
P2PSUSDMar 28 - 07:43204.66

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.